To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- PANATecs moves into new laboratories in Heilbronn in 2012
- Protection against COVID-19: experience is not always an advantage for the immune response - A good response to the SARS-CoV-2 vaccination is based on naive immune cells, whereas pre-existing memory cells are rather disadvantageous
- When does it make sense to develop a new therapeutic agent? - Criteria that research must meet so that a substance that shows promise in the laboratory can actually be developed into a clinically effective drug
- Rickettsia
- OctoPlus wins new drug delivery evaluation contract for two compounds
